Skip to main content
. 2022 Jan 28;14(3):665. doi: 10.3390/cancers14030665

Figure 2.

Figure 2

Current applications of US radiomics in head and neck oncology. (A) Diagnostic applications (left) based on histopathologic findings for the differentiation of benign and malignant thyroid nodules, as well as the classification of lymph node metastasis. Prognostic applications (middle) based on patient outcomes, such as disease-free survival, or response to treatment (Rx response), such as locoregional recurrence. Prediction of treatment toxicity (right) due to salivary gland injury from radiation therapy. (B) Number of publications grouped by clinical task or application.